000 01062nam a2200325 a 4500
005 20250914102115.0
008 010817s2000 nz 001 0 eng b
020 _a0864710658
_cRM320.96
039 9 _a200201211545
_bharisom
_c200111191130
_dlinda
_c200111191128
_dlinda
_y08-17-2001
_zrasida
060 _aQV771
090 _aQV771.O61 2000 9HUKM n.1
245 0 0 _aOpinion & evidence :
_bdrug safety /
_ceditor, I. Ralph Edwards
246 3 0 _aDrug safety
250 _a2nd ed.
260 _aAuckland :
_bAdis International,
_c2000
300 _a(various pagings) ;
_c26 cm.
650 2 _aDrugs
_xSide effects
650 2 _aDrugs
_xSafety measures
650 2 _aDrugs
_xTesting
650 2 _aPharmacovigilance
700 1 _aEdwards, I. Ralph
907 _a.b12897899
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV771.O61 2000 9HUKM n.1
914 _avtls000301232
949 _o0900209627 (n.1)
_o0900209628 (n.2)
990 _ahar
991 _aJabatan Farmasi, HUKM
998 _ah
_b2001-04-08
_cm
_da
_feng
_gnz
_y0
_z.b12897899
999 _c290295
_d290295